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Introduction:  Measured gene-by-environment interaction studies have typically been conducted 
in a candidate GxE (cGxE) fashion, analogous to the candidate gene association studies that were 
used to search for genetic main effects.  Such cGxE research in psychiatry has received 
widespread attention and acclaim, yet cGxE findings are also controversial.  We were interested 
in determining whether cGxE findings were robust and might help to explain some of the 
missing heritability in psychiatric genetics or if, in aggregate, cGxE findings were consistent 
with the existence of publication bias, low power, multiple testing, and type I errors in the cGxE 
literature in psychiatry.   
Method:  We applied modified meta-analytic procedures to all published studies (to our 
knowledge) from the first decade of cGxE research in psychiatry, 2000-2009, collapsing across 
reported interactions in order to identify prevailing trends.   
Results:  Most novel cGxE studies were significant (96%), but only a minority of replication 
attempts were significant (32%).  These findings are consistent with the existence of publication 
bias among novel GxE studies.  There may also be publication bias among replication attempts 
because significant replication attempts had smaller sample sizes, on average, than null 
replication attempts.  Furthermore, rates of positive replications, observed sample sizes, and 
power calculations suggested that studies were underpowered.  Additionally, patterns of 
iv 
expanding and branching hypotheses have been reported across time, and could be partially due 
to multiple testing and publication bias.  Finally, through simulations we show that low power 
biases the observed form of interactions (i.e., ‘crossover’ versus ‘non-crossover’). 
Conclusion:  These results are consistent with the hypothesis that published studies provide a 
biased representation of all cGxE tests that have been conducted and also suggest that many 
reported positive findings may be type I errors.  
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Chapter 1 
Introduction 
 
 Numerous gene-environment interactions (GxEs) have been reported in psychiatry, 
appearing in high-profile journals such as Science, PNAS, and JAMA (Binder, et al., 2008; Caspi, 
et al., 2002; Caspi, et al., 2003; Kaufman, et al., 2004).  They appear to explain some of the 
‘missing heritability’ that has been elusive in psychiatric genetics despite extensive linkage, 
candidate gene, and genome-wide association studies (GWASs) (Manolio, et al., 2009).  But 
critics wonder if these results are too good to be true.  Roughly a decade ago, similar papers that 
described direct effects of candidate genes (i.e., association studies) were published in Science 
(Lesch, et al., 1996), Nature Genetics (Lesch, et al., 1996), and other prominent journals.  
Subsequently, most of the associations failed to replicate (Colhoun, McKeigue, & Smith, 2003; 
Kluger, Siegfried, & Ebstein, 2002; Munafo, et al., 2003; Schinka, Letsch, & Crawford, 2002), 
and based on the observed rate of failures to replicate, Colhoun estimated that 95% of positive 
association results were actually type I errors (Colhoun, et al., 2003).  Does the same fate await 
GxE studies?  This thesis examines studies from the first decade of candidate GxE (cGxE) 
research in psychiatry (2000-2009) and finds evidence consistent with the existence of 
publication bias, low power, multiple testing, and type I errors among positive cGxE findings in 
psychiatry. 
 
1.1  Reasons to expect GxEs in psychiatric genetics 
 Gene-environment interactions (GxEs) occur when the effect of the environment depends 
on one’s genotype or, equivalently, when the effect of one’s genotype depends on the 
2 
 
environment.  There are strong theoretical reasons to believe that GxEs exist (Moffitt, Caspi, & 
Rutter, 2005; Rutter, Thapar, & Pickles, 2009).  For one, GxE effects can be conceptualized as 
main effects of genes if the phenotype is ‘response to the environment.’  For example, ‘change in 
depression in response to stressful life events’ would be a ‘response to the environment’ 
phenotype.  Given that genetic influences on behavior are ubiquitous e.g., (Eaves, Last, Young, 
& Martin, 1978), it stands to reason that ‘response to the environment’ phenotypes would also be 
heritable.  Thus, the existence of GxEs can be inferred. 
 More importantly however, many lines of evidence support the existence of GxEs.  In 
animals, the Siamese cat provides a validated example of a GxE in which genetic background 
and temperature interact to produce the distinctive appearance of the cat (Imes, Geary, Grahn, & 
Lyons, 2006; Lyons, Imes, Rah, & Grahn, 2005).  A temperature-dependent enzyme causes the 
face, tail, paws, and other extremities of the cat (i.e. the colder parts) to be darker colored than 
the body (Imes, et al., 2006; Lyons, et al., 2005).  In humans, a well-known GxE involves 
phenylketonuria, PKU, a condition which only develops in individuals who consume a typical 
diet and have risk genotypes; the disorder is treatable among individuals with risk genotypes if a 
low phenylalanine diet is consumed (Pietz, et al., 1999).  For these and other examples, specific 
genetic risk loci and environmental variables involved in the interaction have been identified 
(Imes, et al., 2006; Lyons, et al., 2005; Pietz, et al., 1999).   
Candidate GxE (cGxE) studies, in which a risk locus is hypothesized and all variables in 
the interaction are measured, attempt to characterize specific interactions (Moffitt, et al., 2005) 
such as those mentioned in the preceding paragraph, and cGxE studies involving psychiatric 
phenotypes are the subject of this thesis.  We are aware of 97 cGxE studies conducted in the first 
decade of such research in psychiatry - a majority of which reported positive results.  The most 
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often studied cGxE in all of psychiatry, first examined by Caspi and colleagues, involves a 
putative interaction between a serotonin transporter related polymorphism (5-HTTLPR) and 
stressful life events in predicting depression (‘Depression ~ 5-HTTLPR x Stressful life events’) 
(Caspi, et al., 2003).  This interaction and closely related variants have been studied over 30 
times, with mixed results (Duncan, Willcutt, & Keller, 20--).   To date, two meta-analyses have 
failed to find support for the original interaction (Munafo, Durrant, Lewis, & Flint, 2009; Risch, 
et al., 2009), suggesting that the original report was a type I error or that the effect is not robust.  
Only one other interaction has been subjected to meta-analysis in cGxE research in psychiatry, 
and it also involved an interaction initially reported by Caspi and colleagues: ‘Antisocial 
problems ~ MAOA x Maltreatment’ (Caspi, et al., 2002; Kim-Cohen, et al., 2006).  While the 
results of the meta-analysis (co-authored by Caspi and colleagues) were favorable, we believe 
that they should be regarded with some caution for three reasons.  First, the original study 
(Caspi, et al., 2002) was included in the meta-analysis (Kim-Cohen, et al., 2006).  Second, a 
study that received widespread criticism was included in the meta-analysis (Foley and Riley 
2007; Joober, Sengupta et al. 2007; Thapar, Harold et al. 2007)(Kim-Cohen, et al., 2006).  Third, 
the selection of which results to use (from new data reported in conjunction with the meta-
analysis) (Kim-Cohen, et al., 2006) was debatable because significant results were selected 
instead of non-significant results, even though the interaction yielding non-significant results was 
arguably more similar to the original interaction.  While the results of the meta-analysis were 
significant, an independent meta-analysis is warranted.  A number of other interactions have 
been examined in multiple studies (Duncan, et al., 20--),  and they serve as excellent candidates 
for replication attempts and eventually meta-analyses, which will provide empirical evidence 
regarding whether or not cGxE findings in psychiatry are robust.   
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 While no specific cGxEs in psychiatry have been unequivocally supported, results from 
latent variable analyses suggest that interactions involving psychiatric phenotypes exist.  Latent 
variable analyses (e.g. twin studies) estimate genetic risk based on genetic relatedness, as 
opposed to cGxE studies, which measure specific polymorphisms directly.  Furthermore, by 
measuring genetic effects in aggregate, such studies may be able to detect cumulative genetic 
effects, composed of many small effects, which might be difficult to detect individually.  Latent 
variable studies have shown that people with low genetic risk are less likely to develop 
depression in response to stressful life events (Kendler, et al., 1995) and that people with high 
genetic risk are more susceptible to developing conduct problems in response to maltreatment 
(Jaffee, et al., 2005).  Studies such as these provide a compelling rationale to search for specific 
cGxEs in psychiatry.  Furthermore, latent variable studies indicate that both genes and the 
environment are important etiological factors in psychiatric disorders.  Heritability estimates for 
depression, bipolar disorder, schizophrenia, eating disorders, and ADHD range from 
approximately 40 to 90% (Burmeister, McInnis, & Zollner, 2008; Craddock, O'Donovan, & 
Owen, 2005; Faraone, 2000; Sullivan, Kendler, & Neale, 2003; Sullivan, Neale, & Kendler, 
2000).  Such heritability estimates bolstered the rationale to hunt for direct effects of 
polymorphisms, and they are often included in the rationale for testing specific cGxEs e.g., 
(Becker, El-Faddagh, Schmidt, Esser, & Laucht, 2008; Moffitt, Caspi, & Rutter, 2006).   
 
1.2 Reasons for caution regarding cGxE studies in psychiatry 
 Despite the reasons supporting the search for cGxEs in psychiatry, there are also reasons 
to be skeptical of such findings.  One criticism of cGxE research stems from the fact that 
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extensive searches for genetic main1 effects in psychiatry, using linkage, candidate gene, and 
GWA studies, have yet to explain much of the heritability of psychiatric disorders (Burmeister, 
et al., 2008; Colhoun, et al., 2003; Collins, 2010; Manolio, et al., 2009).  Given that power to 
detect interactions is lower than power to detect main effects (assuming equal effect sizes) 
(McClelland & Judd, 1993), detecting robust GxEs may be even more difficult than detecting 
genetic main effects.  The fundamental problem described here is low power. 
 Another problem for cGxE studies is the inherently high risk of type I errors, (i.e., ‘false 
positives’ that indicate the existence of an interaction when there is no real interaction).  The 
high risk of type I errors is due to the virtually unlimited number of GxE hypotheses that could 
be tested, coupled with the standard practice of using p < 0.05 as the threshold for statistical 
significance.  The number of testable GxE hypotheses is the product of the number of genotypic, 
phenotypic, and environmental variables available for study; thus, the magnitude of the multiple 
testing problem is demonstrated by the fact that there are over a million genetic polymorphisms 
available for study by researchers who are interested in tens of psychiatric disorders and tens of 
environmental variables in cGxE studies (Duncan, et al., 20--).  Therefore 100 million is a 
conservative estimate for the number of testable GxE hypotheses (1 million * 10 * 10).  Even 
with a more modest example, which is likely to be more representative of variables available to 
individual researchers, of two genetic polymorphisms, two phenotypes, and five environmental 
variables, 20 tests can be conducted.  On average, one test will be ‘significant’ (i.e. p < 0.05) if 
corrections are not made for multiple testing.  Furthermore, given that interaction hypotheses can 
be tested in many different ways using alternative measures of variables and alternative ways of 
coding variables (i.e. a continuous variable can be dichotomized, additive genetic effects can be 
                                                
 1 Throughout this paper ‘main’ effect refers to the effect of a genetic or environmental 
variable in a regression model that does not include an interaction term.   
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recoded to reflect recessive, dominant, or other effects, etc.), many more statistical tests are 
possible.  As Sullivan (2007) articulated with respect to candidate gene association studies, the 
variety of options for testing alternative hypotheses makes finding ‘significant’ results highly 
likely, and the problem is even greater in cGxE studies because of the additional variable. 
Given the magnitude of this multiple testing problem, the concern is that a tremendous 
number of GxE hypotheses will be tested, but only those that are ‘significant’ (without correction 
for multiple testing) will make their way to publication.  This is the phenomenon of publication 
bias, and it produces a distorted representation of findings in a particular area of study.  It also 
increases the field-wise type I error rate (Ioannidis, 2005).  Thus, multiple testing, publication 
bias, and type I errors are a major concern for cGxE research.  
 Another concern about cGxE research, which pertains more broadly to the detection of all 
interactions, is the possibility that an ‘interaction’ may actually be an artifact due to 
distributional properties of variables or scaling effects (Eaves, 2006).  Such artifactual 
interactions can be detected at alarmingly high rates, as high as 100 percent of the time, given 
certain conditions (Eaves, 2006).  While these conditions are not likely (indeed, they cannot be 
true for all interactions because numerous null reports of cGxEs are available), they illustrate the 
point that statistical interactions can be misleading.  Furthermore, as noted by Eaves, an artifact 
can also be replicated, perhaps even more easily than a real interaction, and thus consistent 
replication attempts may not be evidence of true interactions (Eaves, 2006).  
 
1.3   Motivation for thesis 
 In a companion paper that reviews the first decade of cGxE research in psychiatry (2000-
2009), we summarize the replication status of all interactions, including the fact that only two 
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interactions have been studied enough times to warrant meta-analyses (Caspi, et al., 2002; Caspi, 
et al., 2003; Duncan, et al., 20--; Kim-Cohen, et al., 2006; Munafo, et al., 2009; Risch, et al., 
2009).  Therefore, strict meta-analyses provide a limited window through which to view all of 
cGxE research in psychiatry (Duncan, et al., 20--; Rutter, et al., 2009).  Consequently, we 
collapse across interactions in this paper and employ modified meta-analytic procedures, as 
allowed by the data.  Our goal is to determine if the literature, in aggregate, supports the validity 
of cGxE findings or whether it is consistent with the existence of publication bias, low power, 
type I errors, and multiple testing in the cGxE literature in psychiatry. 
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Chapter 2 
Studies Included 
 
 We attempted to find all cGxE studies conducted in the first decade of cGxE research in 
psychiatry, 2000-2009 (inclusive).  Studies were identified using Medline, Pubmed, and Google 
Scholar using combinations of the following search terms: gene*, environment*, interact*, 
psych*, and moderate*.  In addition, bibliographies were hand-searched for cGxE studies.  In 
order to be included, the phenotype in a cGxE study had to be a DSM-IV diagnosis (Association, 
1994) or a closely-related construct (e.g., neuroticism).  Only observational, as opposed to 
experimental, studies were included; thus all pharmacogenetic studies were excluded.  Studies 
were only included if there was variation across participants for phenotypic, genetic, and 
environmental variables.  When follow-up studies of previously published reports were 
available, we included only the follow-up studies.  In total, 97 studies, encompassing 101 
samples, met inclusion criteria.  Details about these studies are available in (Duncan, et al., 20--), 
and a chart of included studies is available in the appendix.  To the best of our knowledge, these 
are all of the cGxE studies published in the first decade of cGxE research in psychiatry 
(Aguilera, et al., 2009; Altink, et al., 2008; Amstadter, et al., 2009; Bakermans-Kranenburg & 
van Ijzendoorn, 2006; Bau, Almeida, & Hutz, 2000; Becker, et al., 2008; Bet, et al., 2009; 
Binder, et al., 2008; Blomeyer, et al., 2008; Bradley, et al., 2008; Brookes, et al., 2008; 
Brummett, et al., 2008; Caspi, et al., 2002; Caspi, et al., 2005; Caspi, et al., 2003; Cervilla, et al., 
2007; Chipman, et al., 2007; Chorbov, et al., 2007; Chotai, Serretti, Lattuada, Lorenzi, & Lilli, 
2003; Cicchetti, Rogosch, & Sturge-Apple, 2007; Covault, et al., 2007; Dick, et al., 2006; 
DiLalla, Elam, & Smolen, 2009; Ducci, et al., 2008; Eley, et al., 2004; Foley, et al., 2004; Fox, et 
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al., 2005; Frazzetto, et al., 2007; Gacek, Conner, Tennen, Kranzler, & Covault, 2008; Gervai, et 
al., 2007; Gibb, McGeary, Beevers, & Miller, 2006; Gillespie, Whitfield, Williams, Heath, & 
Martin, 2005; Grabe, et al., 2005; Grabe, et al., 2009; Gunthert, et al., 2007; Haberstick, et al., 
2005; Haeffel, et al., 2008; Henquet, et al., 2009; Huizinga, et al., 2006; Jacobs, et al., 2006; 
Jokela, Keltikangas-Jarvinen, et al., 2007; Jokela, Lehtimaki, & Keltikangas-Jarvinen, 2007a, 
2007b; Jokela, Raikkonen, Lehtimaki, Rontu, & Keltikangas-Jarvinen, 2007; Kahn, Khoury, 
Nichols, & Lanphear, 2003; Kaufman, et al., 2007; Kaufman, et al., 2006; Kaufman, et al., 2004; 
Keltikangas-Jarvinen, Raikkonen, Ekelund, & Peltonen, 2004; Kendler, Kuhn, Vittum, Prescott, 
& Riley, 2005; Kilpatrick, et al., 2007; Kim, et al., 2007; Kim-Cohen, et al., 2006; Koenen, et al., 
2009; Lahti, et al., 2006; Langley, et al., 2008; J. Lasky-Su, et al., 2007; Laucht, et al., 2007; 
Laucht, Treutlein, Blomeyer, et al., 2009; Laucht, Treutlein, Schmid, et al., 2009; Madrid, 
MacMurray, Lee, Anderson, & Comings, 2001; Neuman, et al., 2007; Nilsson, et al., 2006; 
Nobile, et al., 2007; Nobile, et al., 2009; Ozkaragoz & Noble, 2000; Perroud, et al., 2008; 
Polanczyk, et al., 2009; Power, et al., 2010; Prom-Wormley, et al., 2009; Propper, Willoughby, 
Halpern, Carbone, & Cox, 2007; Racine, Culbert, Larson, & Klump, 2009; Reif, et al., 2007; 
Retz, et al., 2008; Roy, Hu, Janal, & Goldman, 2007; Scheid, et al., 2007; Seeger, Schloss, 
Schmidt, Ruter-Jungfleisch, & Henn, 2004; Sjoberg, et al., 2006; Sjoberg, et al., 2007; Sonuga-
Barke, et al., 2009; Stein, Schork, & Gelernter, 2008; Stevens, et al., 2009; Sun, et al., 2008; 
Surtees, et al., 2006; Taylor, et al., 2006; Todd & Neuman, 2007; van Winkel, et al., 2008; 
Vanyukov, et al., 2007; Waldman, 2007; Wichers, et al., 2008; Widom & Brzustowicz, 2006; 
Wilhelm, et al., 2006; Xu, et al., 2009; Yen, Rebok, Yang, & Lung, 2008; Young, et al., 2006; 
Zalsman, et al., 2006; Zhang, et al., 2009).  
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Chapter 3 
Detecting publication bias in the cGxE literature in psychiatry 
 
 Publication bias, the tendency to publish significant findings instead of null results2, is 
problematic because it produces a distorted representation of findings in an area of study.  
Publication bias can occur if authors decide not to submit null results or if journal editors opt not 
to publish them.  For example, if twenty samples were tested for the presence of an ‘interaction’ 
that was not real, on average, one of them would yield a p-value <.05.  Due to publication bias, 
the ‘significant’ result (i.e. the one with p<.05) might be the only one to be published.  Examined 
alone, the significant finding might appear compelling, whereas the finding would appear 
compatible with chance if all twenty tests had been reported together.  This illustrates how 
publication bias can lead to inappropriate interpretations about the likelihood that a finding could 
have occurred by chance alone.   
 
3.1 Putative publication bias among novel cGxE studies 
 An indirect way to determine whether or not publication bias has occurred in the cGxE 
literature is to examine the rate of null results among novel cGxE studies compared to the rate of 
null results among replication attempts3.  Publication bias could work as follows: null, novel 
results might be deemed uninteresting or difficult to interpret because of power, therefore they 
might not be published.  In contrast, following a significant report of a cGxE, both null and 
                                                
 2 Other forms of publication bias are possible, but we only consider positive publication 
bias (i.e. disproportionate publication of positive results) in this report. 
 3 For all studies, we identified interactions mentioned or alluded to in the abstract.  For 
replication attempts, results were considered to be null if the originally reported interaction was 
not replicated.   
11 
 
significant results for replication attempts might be deemed to be worthy of publication.  
Therefore, the rate of null results would be lower among novel reports than replication attempts.  
This is exactly what we found in the cGxE literature in psychiatry.  As shown in figure 1, a mere 
4% of novel studies were null versus 68% of replication attempts (chi-sq = 35.6, df = 1, p = 2.4e-
9).  The p-value reported here should be interpreted with caution because many of the replication 
attempts were not independent (e.g., the ‘Depression ~ 5-HTTLPR x Stressful life events’ 
interaction was tested multiple times, violating the assumption of independence).  Therefore we 
re-ran the analysis, excluding all but the first published replication attempt for each interaction.  
Despite the reduction in replication attempts available for analysis and the attendant loss of 
power, the results were still highly significant (p = 3.3e-5).  These results suggest that 
publication bias may exist among novel GxE studies.  
 
Figure 1. Evidence consistent with hypothesis of publication bias among novel cGxE studies 
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3.2 Putative publication bias among replication attempts 
 The preceding analyses relied on the assumption that replication attempts are a better 
representation of reality than novel reports, but it is also possible that publication bias exists 
among replication attempts.  If so, our results would be conservative because 68% would be an 
underestimate of the true percentage of replication attempts that are null.  To evaluate this 
possibility, we focused on replication attempts of previously reported, significant interactions.  
There were 39 such replication attempts, which corresponded to 12 originally-reported 
interactions.  We reasoned that two relationships might be observed between sample size and the 
significance (significant versus null) of replication attempts.  First, if the cGxE effects are real, 
then significant (p< .05) replication attempts should have larger sample sizes, on average, than 
null replication attempts given their greater power (Cohen, 1992)4.  Alternatively, if the 
originally reported interaction was a type I error and there was publication bias among 
replication attempts, then significant replication attempts might have smaller sample sizes, on 
average, than null replication attempts.  This would be the case if a cGxE finding was a type I 
error, and many research groups attempted to replicate the finding.  ‘Replications’ would be 
detected at a rate of approximately alpha (i.e. 5%) and due to publication bias, small studies 
might be preferentially published if they had significant results.  Meanwhile, large replication 
attempts might be published irrespective of results (yielding a higher fraction of null results 
among larger than smaller studies). 
 Figure 2 shows evidence consistent with the hypothesis of publication bias among 
replication attempts.  The mean sample size of significant replication attempts was 217, whereas 
                                                
 4 This assumes that the interaction is real, has a large enough effect size to be detected, 
and that there are no systematic differences between smaller and larger samples.  Potential 
confounding differences are discussed in the interpretation of these results. 
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the mean sample size of null replication attempts was 706 (W=49, p=.001).  The nonparametric 
Wilcoxon rank-sum test was used because sample sizes were not normally distributed.  However, 
parametric tests, with and without removal of outliers, were also significant.  The same 
relationship that was observed in this aggregate analysis was also observed for each of the four 
interactions that allowed individual analysis, although none of the individual analyses reached 
statistical significance.  Thus, the observation of smaller sample sizes among significant 
replication attempts is not confined to one interaction.  If publication bias is the correct 
explanation for these results, than more than 68% of replication attempts were actually null.  As 
the true percentage of replication attempts that do not achieve significant p-values (p <  0.05) 
approaches 95%, it becomes more and more plausible that original findings were type I errors. 
 However, we note that publication bias may not be the correct explanation for the fact 
that significant replication attempts had smaller sample sizes than null replication attempts.  It is 
also possible that there are systematic differences between larger and smaller studies.  For 
example, quality of measurement may vary with sample size.  If smaller studies had less 
measurement error, then they might afford more power than larger studies.  Differences in study 
populations could also be to blame.  These and other explanations cannot be ruled out. 
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Figure 2. Evidence consistent with the hypothesis of publication bias among replication 
attempts of cGxE studies 
 
     Null replication attempts had larger sample sizes than significant replication attempts 
 
3.3 Implications 
 We contend that publication bias provides a parsimonious explanation for our results.  If 
true, many more tests of cGxE hypotheses have been conducted than reported in the literature.  
In essence, publication bias may be acting as a filter that catches the 5% of cGxE hypotheses 
that, by chance alone, reach statistical significance.  To the extent that this is true, the field-wise 
type I error rate will be elevated and cGxE hypotheses will appear more credible than they 
actually are.  As suggested by Sullivan regarding novel reports from association studies, we 
recommend that novel reports of cGxEs be treated with “exceptional caution” (Sullivan, 2007).  
If publication bias exists among replication attempts, as our results suggest that it may, then 
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replication attempts deserve cautious interpretation as well, and efforts to determine if cGxE 
findings are robust will be hampered. 
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Chapter 4 
Power to detect GxEs of various effect sizes 
 
 Power to detect GxEs depends on sample size, the effect size of the interaction, 
ascertainment strategy, and the distribution of genetic and environmental variables.   Figure 3 
depicts power to detect GxEs across the range of sample sizes from published cGxE studies for 
three effect sizes: ‘tiny’ (accounting for 0.1% of phenotypic variation), ‘small’ (1%), and ‘large’ 
(10%).  A histogram of sample sizes from published cGxE studies is given in the bottom portion 
of Figure 3, displaying the positively skewed distribution of sample sizes with a median of 345 
but a range of 30 - 4,175.  For these power calculations we assumed unselected samples and 
binary distributions for the genetic and environmental variables (with p=0.5).   
 
4.1  Estimating the effect size of GxEs 
 In order for power calculations to be useful, however, we need estimates of the true effect 
sizes of GxEs.  Given that genetic main effects explain less than one percent of phenotypic 
variance each for psychiatric disorders (Plomin & Davis, 2009), we reasoned that the effect sizes 
of GxEs might be comparable, hence our use of 1% and 0.1%  as estimates of effects sizes for 
GxEs.  Furthermore, GxEs can be conceptualized as main effects of genes if the phenotype is 
‘response to the environment’.  Viewed this way, genetic effects on ‘response to the 
environment’ phenotypes may be comparable to other genetic effects in psychiatric genetics.  
Thus, an upper bound of 1% for the effect size of GxEs might be appropriate.  However, true 
effect sizes of specific GxEs are not known so we also included an effect size ten times larger 
than any known genetic main effect, a GxE accounting for 10% of phenotypic variance. 
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Figure 3. Power calculations for various GxE effect sizes (top graph) and histogram of 
observed sample sizes (bottom graph) 
 
 
4.2 Implications of power calculations and observed sample sizes 
The implications of these power calculations, using observed sample sizes, are sobering.  
For example, assuming an effect size of 1%, two thirds of studies were underpowered.  
Moreover, assuming an effect size of 0.1%, then all studies were underpowered. With power 
estimates this low, the arbitrary choice of alpha level becomes the most important factor in 
18 
 
determining power; thus power would be substantially lower with lower alpha levels. In 
summary, it is very likely that most published cGxE studies were underpowered, perhaps 
severely so. 
 One of the problems with low power is that it necessarily increases the fraction of type I 
errors among positive reports (Green, et al., 2008).  Detection of type I errors can be more likely 
than detection of true effects if power is sufficiently low and/or if the fraction of tested 
hypotheses that are actually true is sufficiently low (Ioannidis, 2005).  In psychiatric genetics, we 
have reason to believe that both power to detect GxEs and the fraction of hypotheses that are 
actually true may be low.  First, as illustrated above, power to detect GxEs may have been very 
low in most published studies.  Second, candidate gene association studies often failed to 
replicate, and in retrospect, it was estimated that 95% of association findings were type I errors 
(Colhoun, et al., 2003).  The same may prove to be true of candidate GxE studies, although 
replication attempts are necessary to test this empirically.  Nevertheless, the possibility that most 
or all positive reports of cGxEs in psychiatry may be type I errors must be acknowledged.   
 Finally, we considered the possibility that GxEs actually had extremely large effects 
sizes.  In order for the median sample size to yield adequate power (80%), the GxE would need 
to account for approximately 27% of phenotypic variance.  The problem with this explanation is 
that it is inconsistent with the observed data: only 32% of replication attempts were significant as 
compared to 80% of replication attempts expected be significant with 80% power.  Instead, the 
results of our power calculations further support the hypothesis of publication bias in the cGxE 
literature because publication bias could explanation the high rate of positive reports in the GxE 
literature (i.e. 96% of novel GxE studies), despite low power (power = alpha because hypotheses 
are actually incorrect).  While these results are important because they apply across all cGxE 
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studies in psychiatry, they may not be applicable to any particular GxE.  Furthermore, as 
discussed in the conclusion section, systematic differences between novel studies and replication 
attempts could also account for these results.   
 
4.3 Rate of type I errors (false positives) in the literature 
 Given findings regarding power and publication bias, it is important to consider the 
prevalence of type I errors is in the cGxE literature in psychiatry.  A rough but conservative 
estimate is that 65% of novel positive reports should actually be null to the extent that the 
following assumptions are correct:  We used the observed percentage of positive replication 
attempts (32%) as a proxy for power5.  Given 32% power, we calculated the number of tests 
(134) necessary to achieve the observed number of statistically significant, novel GxEs (N=43).  
This implies that 3.1 (=134/43) statistical tests were conducted per positive report; thus 
Bonferroni correction (Bonferroni 1936) yields a significance threshold of p < .016.  Sixty-five 
percent of observed p-values for novel GxEs did not survive this correction for multiple testing.  
While this estimate may be useful as a ‘ballpark’ figure, it is extremely rough and should be 
interpreted with a great deal of caution; there is reason to believe that it is an underestimate 
(because of publication bias among replication attempts), but it may also be an overestimate if 
idiosyncratic factors account for the low rate of positive replication attempts. 
 
                                                
 5 However, 32% is likely to be an overestimate of power because of putative publication 
bias among replication attempts.  
20 
 
Chapter 5 
Potential ‘signatures’ of multiple testing, type I errors, low power, and publication bias in the 
cGxE literature in psychiatry. 
 
 In the previous two sections we presented evidence and analyses consistent with the 
presence of publication bias in the cGxE literature and low power to detect GxEs.  These 
problems imply a high rate of type I errors in the literature.  If true, we reasoned that ‘signatures’ 
of these problems might exist across the literature.  In this section we discuss three possible 
signatures of these problems.  However we suggest caution in interpreting putative signatures 
because alternative explanations are possible.  Indeed, they are certainly true to some extent, as 
noted in the following sections. 
 Imagine that a researcher tests a previously reported hypothesis and fails to find support 
for it.  Publishing null results is one option, but another option is to test alternative hypotheses 
involving minor alterations to the original hypothesis.  An incomplete list of possible alterations, 
all of which were reported in the literature, is as follows: 1) genetic variables can be recoded to 
reflect additive, dominant, recessive, and other effects.  Phenotypic and environmental variables 
can be measured continuously and then dichotomized or turned into ordinal variables; 2) 
additional polymorphisms in and around the gene of interest and haplotypes can be added to 
models, as can covariates and additional phenotypic, genetic and environmental variables; 3) 
alternative phenotypic, genotypic, and environmental variables can be tested; for example, 
neuroticism can be tested instead of depression; 4) finally, effects can be tested in sub-samples 
instead of full samples.  Notably, each of these alterations results in a multiplicative increase in 
the number of statistical tests conducted (if all hypotheses are tested systematically), 
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demonstrating the magnitude of the multiple testing problem and the virtual inevitability of 
finding a p-value < .05.  An analogous point about association studies was made by Sullivan 
(2007). 
 
5.1 Expanding and branching hypotheses in the cGxE literature 
 If researchers responded to finding null results for an original hypothesis, such as the 
‘Depression ~ 5-HTTLPR x Stressful life events’ interaction by adding variables and substituting 
alternative variables for those in the original interaction, then we would expect to see patterns of 
expanded and branched hypotheses, respectively, as depicted in Figure 4.  Figure 4A shows a 
series of expanding hypotheses in which additional variables are added to previously-reported 
hypotheses in subsequent studies.  This particular series begins with a direct association 
hypothesis, ends with a 4-way interaction, and encompasses the most often studied cGxE 
hypothesis in all of psychiatry: ‘Depression ~ 5-HTTLPR x Stressful life events’ (Caspi, et al., 
2003; Duncan, et al., 20--; Kaufman, et al., 2006; Kim, et al., 2007; J. A. Lasky-Su, Faraone, 
Glatt, & Tsuang, 2005; Wichers, et al., 2008).  Notably, meta-analyses have failed to support the 
direct association hypothesis and the two-way (5-HTTLPR x Stressful life events) interaction 
hypothesis (J. A. Lasky-Su, et al., 2005; Munafo, et al., 2009; Risch, et al., 2009), findings 
consistent with the possibility that these original reports were type I errors.  The three- and four-
way interactions have not yet been subjected to meta-analyses, so we do not know if they will 
prove to be robust.  However, as the number of terms in an interaction increases, power to detect 
such interactions (with equivalent effect sizes) decreases; so power to detect 3-way interactions 
is lower than power to detect 2-way interactions, and so on (McClelland & Judd, 1993). 
  
Figure 4A. Expanding hypotheses 
Hypotheses can expand via the addition of new variables. 
 
 
 
 
Depression ~ 5-HTTLPR
Depression ~ 5-HTTLPR x
Stressful life 
events
Depression ~ 5-HTTLPR x BDNF x
Stressful life 
events
Depression ~ 5-HTTLPR x BDNF x
Stressful life 
events
x
Social 
support
A. Hypotheses can EXPAND via the addition of new variables 
 
Direct association
2-way interaction
4-way interaction
3-way interaction
Phenotypic variables
Genotypic variables
Environmental variables
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Figure 4B. Branching hypotheses. 
Hypotheses can branch via the substitution of alternative variables 
5-HTTLPR=serotonin transporter-linked polymorphic region, ADHD=attention deficit hyperactivity disorder, PTSD=post-traumatic 
stress disorder, 5-HTR=serotonin receptor, BDNF=brain-derived neurotrophic factor, CRHR1=cortocotropin releasing hormone 
receptor 
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 Forty-nine branched hypotheses are depicted in Figure 4B in which alternative 
phenotypic, genotypic, or environmental variables are substituted for the corresponding variable 
in the original ‘Depression ~ 5-HTTLPR x Stressful life events’ interaction.  A majority, but not 
all of these hypotheses, were reported as significant findings.  The origin of these branched and 
expanded hypotheses has implications for the progress of scientific knowledge.  If positive 
reports of branched and expanded hypotheses were ‘discovered’ via multiple testing and failure 
to correct for statistical tests, then they are likely to slow scientific progress, confuse consumers 
of the literature, and waste research dollars on unpromising replication attempts.  However, 
branched hypotheses may also be constructive additions to the literature.  Carefully planned and 
targeted branched hypotheses may be tested when precise replication attempts are precluded by 
the limitations of extant datasets.  There may also be theoretical reasons to test particular 
branched hypotheses, including efforts to determine the boundary conditions of an originally 
reported hypothesis.  For example, Kendler reported testing an ‘Anxiety ~ 5-HTTLPR x 
Stressful life events’ interaction in order to assess the specificity of the original interaction 
involving depression, and this is a useful contribution to the literature (Kendler, et al., 2005).  In 
addition, researchers may attempt to replicate previously reported branched hypotheses.  Thus, 
branching hypotheses may be beneficial, but continuously branching and expanding hypotheses, 
in the absence of robust effects, may serve as a signature of multiple testing, low power and/or 
type I errors, and publication bias in the cGxE literature.  Future replication attempts and meta-
analyses will be needed to determine if branched and expanded hypotheses replicate or not. 
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5.2 Form of interactions: Reversals of effect (i.e. ‘crossovers’) dominate the cGxE 
literature in psychiatry 
 A third potential signature of publication bias and low power and/or type I errors may 
exist in the observed form of published interactions.  Figure 5 displays the observed proportion 
of interactions with particular forms6.  We use the terms ‘reversal of genetic effect’ and ‘reversal 
of environmental effect’ to describe the form of interactions because these terms allow for more 
nuanced descriptions of the form of interactions than the terms ‘crossover’ and ‘non-crossover’ 
do (see Figure 6).  As shown in Figure 5, only 8% of observed interactions involved no reversals 
(i.e., ‘non-reversal interactions’).  Ninety percent of interactions involved reversals of genetic 
effect and nearly half of interactions (45%) involved reversals of environmental effect.  We 
submit these observations to the literature for others to consider. 
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Figure 5. Reversals of effects in observed and simulated data 
 
 
For this analysis we examined only novel reports of interactions because we didn’t want the form 
of any particular interaction to be overrepresented in this sample (i.e. we attempted to gather a 
representative sample of GxEs in psychiatry).  For the same reason, we examined only the first 
graphed interaction from each novel study. 
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Figure 6.Demonstration of different patterns of reversals in hypothetical interactions 
 
 
 
Hypothetical interactions.  Boxes A and B demonstrate how the terms ‘crossover’ and  ‘non-
crossover’ are ambiguous.  A crossover interaction is observed in A, but no crossover is apparent 
in B.  Importantly, the only difference between A and B is the arbitrary choice of which variable 
(environmental or genetic) is plotted on the x-axis.  Reversal language provides a more nuanced 
description of the form of the interaction graphed in A and B.  This interaction involves a 
reversal of genetic effect (as evidenced by crossed lines in A) and no reversal of environmental 
effect (in B, severe maltreatment is always the risk environment).  An interaction involving 
reversal of environmental but not genetic effect is also possible (not shown), as are interactions 
involving no reversals of effect (C) and reversal of both effects (D).  In total this yield four 
possible forms of interactions. 
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5.2.1 Implications of reversal interactions  
 If these findings are true, then they are quite intriguing because true reversal of effect 
interactions allow for the possibility that large GxEs could exist in the absence of ‘main’ effects 
of environment and/or genotype.  In fact, they are the only type of interaction that can be 
detected if there are no genetic or environmental main effects (Rogers, 2002).  Furthermore, 
researchers should be aware that the effect size of non-reversal interactions is mathematically 
constrained to be 50% or less of the combined effect size of the genetic and environmental main 
effects (Rogers, 2002).  Notably, all published studies without main effects could only detect 
crossover interactions.  Furthermore, those with modest main effects were severely 
underpowered to detect non-crossover interactions.  Thus, if researchers believe, as we do, that 
non-reversal interactions are generally more plausible than reversal interactions, then they should 
search for GxEs involving genetic and environmental variables known to have robust main 
effects on the phenotype of interest, a suggestion that has been offered before (Risch, et al., 
2009).  
We expect non-reversal interactions to be more likely than reversal interactions because 
of the seemingly implausible (to us) scenarios that reversal interactions imply.  Contrary to the 
expectation that a given genotype will be the ‘risk’ genotype across different levels of the 
environment, reversal of genetic effect implies that the risk status of a given genotype will be 
reversed in one environment compared to another.  Similarly, one level of the environment will 
not be the ‘risk’ environment for all people; rather the risk environment will be reversed 
depending on genotype.  Using the example of the ‘Depression ~ 5-HTTLPR x Stressful life 
events’ interaction, a reversal of environmental effect implies that high levels of stressful life 
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events will increase the likelihood of depression for some people but be protective against 
depression for people with certain genotypes.   
Such reversals of effect seem implausible for two reasons.  For one, it is surprising that 
stressful life events could be protective against depression (Kendler, Karkowski, & Prescott, 
1999).  Additionally, such interactions imply that polymorphisms have effects strong enough to 
reverse the effect of the environment, a prospect that seems inconsistent with the typically 
modest effects of individual polymorphisms (Plomin & Davis, 2009).  In contrast, non-reversal 
interactions seem plausible because they imply that genetic variables have subtle influences on 
environmental effects, and vice versa.  In other words, non-reversal interactions imply that the 
magnitude (but not the direction) of genetic effects is influenced by environment.  Similarly, the 
magnitude (but not the direction) of environmental effects is influenced by genotype.  Indeed, it 
seems implausible that genetic and environmental effects are completely impervious to the 
effects of one another.  We provide these explanations merely as a springboard for discussion, 
and reiterate that we do not know the true form of interactions involving psychiatric phenotypes.  
Indeed, a systematic report of interactions in mice found many reversals and also found that 
interaction effects tended to be larger than main effects (Valdar, et al., 2006), which is consistent 
with the presence of reversal interactions.  Thus it may be the case that reversals are common. 
5.2.2 Alternative explanations for reversal interactions in the literature 
Alternatively, the observed profile of results may be inaccurate.  As shown in Figure 5B 
via simulations, low power biases the observed form of interactions; increasing power by 
increasing N changes the observed profile of reversals, even though the form of the true 
interaction does not change.  For the simulation results presented in Figure 5B we conducted 
1,000 runs for each of three scenarios that differed only in terms of sample size (N = 345, 2,000, 
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and 10,000).  For each sample size, the profile of reversals is derived from significant 
interactions only, mimicking the effect of publication bias.  For these simulations, we identified a 
combination of genetic, environmental, and GxE effect sizes (accounting for 0.5%, 1.8%, and 
0.1% of phenotypic variance each) that produced a profile of reversals similar to the observed 
profile of reversals in Figure 5A when power was low (i.e., when N=345).  However, the true 
form of an interaction is dictated by the relative magnitude of genetic, environmental, and GxE 
effects, and this particular combination of effect sizes yields a non-crossover interaction (as 
depicted in Figure 5B).  Therefore, detection of any other form of interaction is inaccurate.  As 
shown in the first simulated bar, the observed form of the interaction is inaccurate most of the 
time.  In the right two columns, we demonstrate that identification of the true form of the 
interaction improves with increasing power.   Thus, low power will bias the form of observed 
interactions. 
Another possibility for the observed profile of reversals is that findings are actually type I 
errors.  We created a profile of reversals identical to the observed profile (data not shown) in a 
variety of simulations involving no real GxE effect.  Thus, another possibility is that the 
observed profile of reversals is entirely misleading because positive results are actually type I 
errors. 
5.2.3  Synthesis of information regarding the form of published interactions 
The observed profile of reversals may reflect the true form of GxEs in psychiatry.  
However, through simulations we demonstrated two other possibilities: 1) the observed profile of 
interactions may be inaccurate because low power biases the observed form of interactions; 2) 
the observed profile of reversals could be completely inaccurate if it is due to the publication of 
type I errors (data not shown).  Thus, the observed form of an interaction should be interpreted 
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cautiously, and highly powered studies of robust interactions will be needed to determine the true 
form of interactions.  Finally, we apply Rogers’ (2002) findings about mathematical constraints 
on the effect size of non-reversal interactions to GxE studies, noting that non-reversal 
interactions cannot be found in the absence of main effects.  Additionally, samples of thousands 
rather than hundreds of subjects will be necessary for adequate (> 80%) power to identify non-
reversal interactions when main effects are modest (i.e. combined genetic and environmental 
main effects account for 10% or less of phenotypic variance).
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Chapter 6 
Conclusion 
 
 We examined the cGxE literature in psychiatry and found multiple lines of evidence 
consistent with the possibility that many positive reports of cGxEs are type I errors.  In addition, 
we showed that the observed form of an interaction (assuming that it is real) could often be 
incorrect because low power biases the observed form of interactions.  This finding could be 
important for cGxE research in psychiatry because many published studies were likely 
underpowered.  Additionally, we noted patterns of expanding and branching hypotheses in the 
literature, and suggest that such patterns will serve as signatures of type I errors if robust 
interactions are not eventually identified.     
 
6.1 Reasons why a preponderance of type I errors in the cGxE literature in psychiatry 
may not be surprising. 
 The above-mentioned conclusions may sound surprising at first, but we argue that recent 
advances in knowledge about the genetic architecture of psychiatric disorders make them less 
surprising than they would have been even two years ago.   
For one, GxEs can be conceptualized as main effects if the phenotype is ‘response to the 
environment’.  Viewed this way, genetic effects on ‘response to the environment’ phenotypes 
may be comparable in size to other genetic effects in psychiatry, accounting for less than one 
percent of phenotypic variance each (Plomin & Davis, 2009).  If so, then cGxE studies are likely 
to mimic association studies with initially positive reports, followed by mixed and predominately 
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null results, and ultimately few or no robust findings (Dahlman, et al., 2002; Wacholder, 
Chanock, Garcia-Closas, El ghormli, & Rothman, 2004). 
 GxE studies are currently in a ‘candidate GxE’ era, similar to the candidate gene 
association era in which individual association hypotheses were tested.  This is in contrast to the 
GWAS era, in which hundreds of thousands of association hypotheses are tested simultaneously.  
Notably, nearly all candidate gene association studies failed to replicate (Colhoun, et al., 2003). 
 Three factors likely contributed to the lack of success in candidate gene association 
studies: 1) low power given small effect sizes; 2) inchoate knowledge of the effects of 
polymorphisms, particularly with respect to disease etiology, which typically precluded the 
possibility of accurate a priori hypotheses; and 3) the low prior probability that one given 
polymorphism, out of the millions of possible polymorphisms, had an appreciable effect on a 
phenotype of interest.  Notably, all of these factors are likely to be even more problematic in 
cGxE studies.  First, the effect sizes of GxEs may be comparable to those of genetic main effects 
(this is an unbiased guess; GxE effects may actually be smaller or larger, on average, than 
genetic main effects).  However, power to detect interactions is lower than power to detect main 
effects (of equal effect sizes) (McClelland & Judd, 1993).  Therefore, the power problem that 
plagued association studies may be even worse for candidate GxE studies.  Second, in general, 
even less is known about the interaction of specific polymorphisms with specific environmental 
variables than is known about the main effects of polymorphisms.  Thus, candidate GxE 
hypotheses will tend to be less informed than candidate gene association hypotheses, rendering a 
priori cGxE hypotheses less accurate than a priori association hypotheses, which were usually 
incorrect (Colhoun, et al., 2003).  Third, there are many more potential cGxE hypotheses than 
candidate gene association hypotheses.  Therefore it is likely that the prior probability that any 
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one candidate GxE has an appreciable effect on a phenotype of interest is even lower than the 
prior probability that a particular candidate gene has an effect on a phenotype of interest.  Taken 
together, these factors suggest that identifying robust GxEs may be even more difficult than 
identifying robust genetic main effects and that most or all positive findings may be type I errors.  
However, this assertion is based on the above-mentioned arguments and empirical evidence will 
be needed to definitively determine the promise of cGxE research in psychiatry. 
 
6.2 Limitations 
 There are several limitations in our study that should be considered when interpreting our 
findings.  First, since we collapsed across interactions for our analyses our results cannot be 
applied to any particular interaction.  In other words, what is generally true of cGxE studies in 
psychiatry may not be true for individual interactions.   
 Second, our analyses depended on assumptions about the lack of systematic differences 
between particular groupings of interactions.  An important assumption was that replication 
attempts did not differ from novel reports in systematic ways.  If replication attempts were 
disproportionately devoted to interactions that were, on average, less replicable (e.g., due to type 
I errors, variables that were difficult to measure, and/or small effect sizes), then our finding of 
putative publication bias among novel reports could be exaggerated or incorrect.  In addition, our 
estimate of observed power to detect GxEs (32%, the percentage of positive replication attempts) 
would be an underestimate of the true power to detect the average reported GxE.  We checked to 
see if replication samples were smaller than novel samples, which could render replication 
attempts less powerful and reliable.  However, replication samples, on average, were larger than 
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novel samples (615 versus 536, non-significant difference), so we found no support for this 
particular explanation.   
 Systematic differences between replication attempts and novel studies would not affect 
conclusions about putative publication bias among replication attempts because the relevant 
analyses were restricted to replication attempts.  Instead, as noted previously, systematic 
differences between large and small studies could provide explanations other than publication 
bias for the observation that significant replication attempts tended to have smaller, rather than 
larger, sample sizes than null replication attempts.  For example, if smaller studies used more 
accurate measures, then they might be more powerful by virtue of lower measurement error. 
 Third, our ascertainment strategy could have biased our results.  In general, we probably 
missed some published cGxE studies.  We know of no reason to expect that the studies included 
in this review constitute a biased sample of published cGxE studies, though this possibility 
cannot be ruled out.  Additionally, for our first analysis, we searched for GxEs in the abstracts, 
but not the body of papers.  We did this for two reasons: first, the latter was not feasible because 
it would have required us to look through every paper ever published that examined a genetic 
variant – which is obviously too time consuming.  Second, we confined our search to the 
abstracts in an effort to avoid certain biases.  For example, we might have worked harder to find 
GxEs in the body of some papers rather than others, and this could be a potential source of bias.  
Nevertheless, it is likely that more novel cGxE hypotheses have been reported than we identified.  
To the extent that this is true, our finding of publication bias among novel GxE studies could be 
exaggerated or incorrect. 
 Finally, as with any review or meta-analysis, some subjective decisions were required.  
For example, studies needed to be classified as novel studies OR replication attempts.  Such 
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decisions can be difficult because, in reality, studies exist on a continuum of similarity to 
dissimilarity, and any choice is inherently subjective.  In all analyses we attempted to be as 
unbiased as possible.  Furthermore, for the analysis that involved the greatest number of 
subjective decisions (i.e., the analysis of sample sizes in significant versus non-significant 
replication attempts) we performed a check of potential bias.  First, we coded studies, trying to 
be as unbiased as possible.  Then, we coded studies two other ways: 1) biased toward detecting 
publication bias, and 2) biased against detecting publication bias.  Upon re-running the analyses, 
we found that results were in the same direction for all three methods of coding the data, thought 
the result did not reach statistical significance when data coding was biased against the 
possibility of detecting publication bias.  Thus, we felt confident that these biases were not the 
source of our findings. 
 
6.3 Recommendations for cGxE studies 
  Given our findings we offer three recommendations for future cGxE studies that may 
improve the reliability of reported findings and aid in discerning true from false GxE effects.  
First, researchers should consider power when designing studies.  Second, replication attempts, 
even those with small samples and null results, are valuable contributions to the literature and 
should be afforded such status in journals.  In fact, independent replication attempts are arguably 
more important than novel reports of cGxEs.  Last, all statistical tests that were performed should 
be reported in order to decrease the multiple testing problem and the associated risk of type I 
errors.  Failing to do so clutters the literature with confusing results, slows the progress of 
science, and leads to wasted or poorly appropriated resources.  Additional recommendations are 
provided in our companion paper (Duncan, et al., 20--). 
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6.4 Future directions 
 As has occurred with investigations of main effects of genes, we expect that genome-
wide methodologies will soon supplant the candidate gene approach in GxE research (Khoury & 
Wacholder, 2009; Murcray, Lewinger, & Gauderman, 2009; Sonuga-Barke, et al., 2008).  In 
psychiatry, we know of only one study that included an environmental measure in a GWAS 
design (excluding pharmacogenetic and other experimental studies, as stated in the methods 
section) (Sonuga-Barke, et al., 2008).  This ‘GWASxE’ study examined the interaction of 
approximately half a million SNPs with maternal expressed emotion on the phenotype of ADHD 
(Sonuga-Barke, et al., 2008).  Although the authors found no genome-wide significant results, 
they provided a useful demonstration of the methodology and identified cGxEs for future study 
(Sonuga-Barke, et al., 2008).  Importantly, GWASxE studies could be used to systematically 
look for GxEs with very large effects, which could be clinically useful.  However, it is probably 
more likely that GWASxE studies will suffer from the same problems of low power and 
inadequate sample sizes that have plagued GWAS studies.  Nevertheless, the use of larger 
samples will lead to improved power, and GWASxE methodology will undoubtedly uncover 
some reliable GxEs at some point in the future.  
 
6.5 Final synopsis 
 Taken together, the results of the present study suggest that early failures to replicate 
cGxE interactions such as the ‘Depression ~ 5-HTTLPR x Stressful life events’ interaction 
(Caspi, et al., 2003)(Munafo, et al., 2009; Risch, et al., 2009) may portend more failures of 
replication in the future.  We report our conclusions with some apprehension given concern that 
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true GxEs may be discounted because of these findings.  However, the risk of wasting resources 
on unpromising hypotheses is also a realistic possibility.  In sum, our results provide a rationale 
for interpreting cGxE findings more cautiously and they are consistent with the criticisms of GxE 
research offered by others e.g. (Eaves, 2006; Risch, et al., 2009).  
 
39 
 
Bibliography 
 
Aguilera, M., Arias, B., Wichers, M., Barrantes-Vidal, N., Moya, J., Villa, H., et al. (2009). 
Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions 
on depressive symptoms in a general population. Psychological Medicine, 39(9), 1425-
1432. 
Altink, M. E., Arias-Vasquez, A., Franke, B., Slaats-Willemse, D. I. E., Buschgens, C. J. M., 
Rommelse, N. N. J., et al. (2008). The dopamine receptor D4 7-repeat allele and prenatal 
smoking in ADHD-affected children and their unaffected siblings: no gene-environment 
interaction. Journal of Child Psychology and Psychiatry, 49(10), 1053-1060. 
Amstadter, A. B., Koenen, K. C., Ruggiero, K. J., Acierno, R., Galea, S., Kilpatrick, D. G., et al. 
(2009). Variant in RGS2 moderates posttraumatic stress symptoms following potentially 
traumatic event exposure. Journal of Anxiety Disorders, 23(3), 369-373. 
Association, A. P. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). 
Washington, DC. 
Bakermans-Kranenburg, M. J., & van Ijzendoorn, M. H. (2006). Gene-environment interaction 
of the dopamine D4 receptor (DRD4) and observed maternal insensitivity predicting 
externalizing behavior in preschoolers. Dev Psychobiol, 48(5), 406-409. 
Bau, C. H., Almeida, S., & Hutz, M. H. (2000). The TaqI A1 allele of the dopamine D2 receptor 
gene and alcoholism in Brazil: association and interaction with stress and harm avoidance 
on severity prediction. Am J Med Genet, 96(3), 302-306. 
Becker, K., El-Faddagh, M., Schmidt, M. H., Esser, G., & Laucht, M. (2008). Interaction of 
dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms. 
Journal of Pediatrics, 152(2), 263-269. 
Bet, P. M., Penninx, B. W. J. H., Bochdanovits, Z., Uitterlinden, A. G., Beekman, A. T. F., van 
Schoor, N. M., et al. (2009). Glucocorticoid Receptor Gene Polymorphisms and 
Childhood Adversity Are Associated With Depression: New Evidence for a Gene-
Environment Interaction. American Journal of Medical Genetics Part B-
Neuropsychiatric Genetics, 150B(5), 660-669. 
Binder, E. B., Bradley, R. G., Liu, W., Epstein, M. P., Deveau, T. C., Mercer, K. B., et al. 
(2008). Association of FKBP5 polymorphisms and childhood abuse with risk of 
40 
 
posttraumatic stress disorder symptoms in adults. Jama-Journal of the American Medical 
Association, 299(11), 1291-1305. 
Blomeyer, D., Treutlein, J., Esser, G., Schmidt, M. H., Schumann, G., & Laucht, M. (2008). 
Interaction between CRHR1 gene and stressful life events predicts adolescent heavy 
alcohol use. Biological Psychiatry, 63(2), 146-151. 
Bradley, R. G., Binder, E. B., Epstein, M. P., Tang, Y., Nair, H. P., Liu, W., et al. (2008). 
Influence of child abuse on adult depression: moderation by the corticotropin-releasing 
hormone receptor gene. Arch Gen Psychiatry, 65(2), 190-200. 
Brookes, K. J., Neale, B., Xu, X., Thapar, A., Gill, M., Langley, K., et al. (2008). Differential 
Dopamine Receptor D4 Allele Association With ADHD Dependent of Proband Season of 
Birth. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 
147B(1), 94-99. 
Brummett, B. H., Boyle, S. H., Siegler, I. C., Kuhn, C. M., Ashley-Koch, A., Jonassaint, C. R., et 
al. (2008). Effects of environmental stress and gender on associations among symptoms 
of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). 
Behav Genet, 38(1), 34-43. 
Burmeister, M., McInnis, M. G., & Zollner, S. (2008). Psychiatric genetics: progress amid 
controversy. Nature Reviews Genetics, 9(7), 527-540. 
Caspi, A., McClay, J., Moffitt, T. E., Mill, J., Martin, J., Craig, I. W., et al. (2002). Role of 
genotype in the cycle of violence in maltreated children. Science, 297(5582), 851-854. 
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., et al. (2005). 
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a 
functional polymorphism in the catechol-O-methyltransferase gene: longitudinal 
evidence of a gene X environment interaction. Biol Psychiatry, 57(10), 1117-1127. 
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., et al. (2003). 
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. 
Science, 301(5631), 386-389. 
Cervilla, J. A., Molina, E., Rivera, M., Torres-Gonzalez, F., Bellon, J. A., Moreno, B., et al. 
(2007). The risk for depression conferred by stressful life events is modified by variation 
at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-
Gene cohort. Mol Psychiatry, 12(8), 748-755. 
41 
 
Chipman, P., Jorm, A. F., Prior, M., Sanson, A., Smart, D., Tan, X., et al. (2007). No interaction 
between the serotonin transporter polymorphism (5-HTTLPR) and childhood adversity or 
recent stressful life events on symptoms of depression: Results from two community 
surveys. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 
144B(4), 561-565. 
Chorbov, V. M., Lobos, E. A., Todorov, A. A., Heath, A. C., Botteron, K. N., & Todd, R. D. 
(2007). Relationship of 5-HTTLPR genotypes and depression risk in the presence of 
trauma in a female twin sample. American Journal of Medical Genetics Part B-
Neuropsychiatric Genetics, 144B(6), 830-833. 
Chotai, J., Serretti, A., Lattuada, E., Lorenzi, C., & Lilli, R. (2003). Gene-environment 
interaction in psychiatric disorders as indicated by season of birth variations in 
tryptophan hydroxylase (TPH), serotonin transporter (5-HTTLPR) and dopamine 
receptor (DRD4) gene polymorphisms. Psychiatry Research, 119(1-2), 99-111. 
Cicchetti, D., Rogosch, F. A., & Sturge-Apple, M. L. (2007). Interactions of child maltreatment 
and serotonin transporter and monoamine oxidase A polymorphisms: Depressive 
symptornatology among adolescents from low socioeconomic status backgrounds. 
Development and Psychopathology, 19(4), 1161-1180. 
Cohen, J. (1992). A Power Primer. Psychological Bulletin, 112(1), 155-159. 
Colhoun, H. M., McKeigue, P. M., & Smith, G. D. (2003). Problems of reporting genetic 
associations with complex outcomes. Lancet, 361(9360), 865-872. 
Collins, F. (2010). Has the revolution arrived? Nature, 464(7289), 674-675. 
Covault, J., Tennen, H., Armeli, S., Conner, T. S., Herman, A. I., Cillessen, A. H., et al. (2007). 
Interactive effects of the serotonin transporter 5-HTTLPR polymorphism and stressful 
life events on college student drinking and drug use. Biol Psychiatry, 61(5), 609-616. 
Craddock, N., O'Donovan, M. C., & Owen, M. J. (2005). The genetics of schizophrenia and 
bipolar disorder: dissecting psychosis. Journal of Medical Genetics, 42(3), 193-204. 
Dick, D. M., Agrawal, A., Schuckit, M. A., Bierut, L., Hinrichs, A., Fox, L., et al. (2006). 
Marital status, alcohol dependence, and GABRA2: Evidence for gene-environment 
correlation and interaction. Journal of Studies on Alcohol, 67(2), 185-194. 
42 
 
DiLalla, L. F., Elam, K. K., & Smolen, A. (2009). Genetic and Gene-Environment Interaction 
Effects on Preschoolers' Social Behaviors. Developmental Psychobiology, 51(6), 451-
464. 
Ducci, F., Enoch, M. A., Hodgkinson, C., Xu, K., Catena, M., Robin, R. W., et al. (2008). 
Interaction between a functional MAOA locus and childhood sexual abuse predicts 
alcoholism and antisocial personality disorder in adult women. Molecular Psychiatry, 
13(3), 334-347. 
Duncan, L. E., Willcutt, E. G., & Keller, M. C. (20--). Empirical review of the first decade of 
mGxE research in psychiatry. 
Eaves, L. J. (2006). Genotype x Environment interaction in psychopathology: fact or artifact? 
Twin Res Hum Genet, 9(1), 1-8. 
Eaves, L. J., Last, K. A., Young, P. A., & Martin, N. G. (1978). Model-Fitting Approaches to the 
Analysis of Human-Behavior. Heredity, 41(Dec), 249-320. 
Eley, T. C., Sugden, K., Corsico, A., Gregory, A. M., Sham, P., McGuffin, P., et al. (2004). 
Gene-environment interaction analysis of serotonin system markers with adolescent 
depression. Mol Psychiatry, 9(10), 908-915. 
Faraone, S. V. (2000). Genetics of childhood disorders: XX. ADHD, Part 4: is ADHD 
genetically heterogeneous? J Am Acad Child Adolesc Psychiatry, 39(11), 1455-1457. 
Foley, D. L., Eaves, L. J., Wormley, B., Silberg, J. L., Maes, H. H., Kuhn, J., et al. (2004). 
Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch 
Gen Psychiatry, 61(7), 738-744. 
Fox, N. A., Nichols, K. E., Henderson, H. A., Rubin, K., Schmidt, L., Hamer, D., et al. (2005). 
Evidence for a gene-environment interaction in predicting behavioral inhibition in middle 
childhood. Psychol Sci, 16(12), 921-926. 
Frazzetto, G., Di Lorenzo, G., Carola, V., Proietti, L., Sokolowska, E., Siracusano, A., et al. 
(2007). Early Trauma and Increased Risk for Physical Aggression during Adulthood: The 
Moderating Role of MAOA Genotype. Plos One, 2(5), -. 
43 
 
Gacek, P., Conner, T. S., Tennen, H., Kranzler, H. R., & Covault, J. (2008). Tryptophan 
hydroxylase 2 gene and alcohol use among college students. Addiction Biology, 13(3-4), 
440-448. 
Gervai, J., Novak, A., Lakatos, K., Toth, I., Danis, I., Ronai, Z., et al. (2007). Infant genotype 
may moderate sensitivity to maternal affective communications: attachment 
disorganization, quality of care, and the DRD4 polymorphism. Soc Neurosci, 2(3-4), 307-
319. 
Gibb, B. E., McGeary, J. E., Beevers, C. G., & Miller, I. W. (2006). Serotonin transporter (5-
HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric 
inpatients. Suicide Life Threat Behav, 36(6), 687-693. 
Gillespie, N. A., Whitfield, J. B., Williams, B., Heath, A. C., & Martin, N. G. (2005). The 
relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype 
and major depression. Psychol Med, 35(1), 101-111. 
Grabe, H. J., Lange, M., Wolff, B., Volzke, H., Lucht, M., Freyberger, H. J., et al. (2005). 
Mental and physical distress is modulated by a polymorphism in the 5-HT transporter 
gene interacting with social stressors and chronic disease burden. Mol Psychiatry, 10(2), 
220-224. 
Grabe, H. J., Spitzer, C., Schwahn, C., Marcinek, A., Frahnow, A., Barnow, S., et al. (2009). 
Serotonin Transporter Gene (SLC6A4) Promoter Polymorphisms and the Susceptibility 
to Posttraumatic Stress Disorder in the General Population. American Journal of 
Psychiatry, 166(8), 926-933. 
Green, A. E., Munafo, M. R., DeYoung, C. G., Fossella, J. A., Fan, J., & Gray, J. R. (2008). 
Using genetic data in cognitive neuroscience: from growing pains to genuine insights. 
Nature Reviews Neuroscience, 9(9), 710-720. 
Gunthert, K. C., Conner, T. S., Armeli, S., Tennen, H., Covault, J., & Kranzler, H. R. (2007). 
Serotonin transporter gene polymorphism (5-HTTLPR) and anxiety reactivity in daily 
life: a daily process approach to gene-environment interaction. Psychosom Med, 69(8), 
762-768. 
Haberstick, B. C., Lessem, J. M., Hopfer, C. J., Smolen, A., Ehringer, M. A., Timberlake, D., et 
al. (2005). Monoamine oxidase A (MAOA) and antisocial behaviors in the presence of 
childhood and adolescent maltreatment. Am J Med Genet B Neuropsychiatr Genet, 
135B(1), 59-64. 
44 
 
Haeffel, G. J., Getchell, M., Koposov, R. A., Yrigollen, C. M., Deyoung, C. G., Klinteberg, B. 
A., et al. (2008). Association between polymorphisms in the dopamine transporter gene 
and depression: evidence for a gene-environment interaction in a sample of juvenile 
detainees. Psychol Sci, 19(1), 62-69. 
Henquet, C., Rosa, A., Delespaul, P., Papiol, S., Fananas, L., van Os, J., et al. (2009). COMT 
Val(158)Met moderation of cannabis-induced psychosis: a momentary assessment study 
of 'switching on' hallucinations in the flow of daily life. Acta Psychiatrica Scandinavica, 
119(2), 156-160. 
Huizinga, D., Haberstick, B. C., Smolen, A., Menard, S., Young, S. E., Corley, R. P., et al. 
(2006). Childhood maltreatment, subsequent antisocial behavior, and the role of 
monoamine oxidase A genotype. Biological Psychiatry, 60(7), 677-683. 
Imes, D. L., Geary, L. A., Grahn, R. A., & Lyons, L. A. (2006). Albinism in the domestic cat 
(Felis catus) is associated with a tyrosinase (TYR) mutation. Animal Genetics, 37(2), 
175-178. 
Ioannidis, J. P. A. (2005). Why most published research findings are false. Plos Medicine, 2(8), 
696-701. 
Jacobs, N., Kenis, G., Peeters, F., Derom, C., Vlietinck, R., & van Os, J. (2006). Stress-related 
negative affectivity and genetically altered serotonin transporter function: evidence of 
synergism in shaping risk of depression. Arch Gen Psychiatry, 63(9), 989-996. 
Jaffee, S. R., Caspi, A., Moffitt, T. E., Dodge, K. A., Rutter, M., Taylor, A., et al. (2005). Nature 
X nurture: genetic vulnerabilities interact with physical maltreatment to promote conduct 
problems. Dev Psychopathol, 17(1), 67-84. 
Jokela, M., Keltikangas-Jarvinen, L., Kivimaki, M., Puttonen, S., Elovainio, M., Rontu, R., et al. 
(2007). Serotonin receptor 2A gene and the influence of childhood maternal nurturance 
on adulthood depressive symptoms. Arch Gen Psychiatry, 64(3), 356-360. 
Jokela, M., Lehtimaki, T., & Keltikangas-Jarvinen, L. (2007a). The influence of urban/rural 
residency on depressive symptoms is moderated by the serotonin receptor 2A gene. 
American Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 144B(7), 918-
922. 
45 
 
Jokela, M., Lehtimaki, T., & Keltikangas-Jarvinen, L. (2007b). The serotonin receptor 2A gene 
moderates the influence of parental socioeconomic status on adulthood harm avoidance. 
Behav Genet, 37(4), 567-574. 
Jokela, M., Raikkonen, K., Lehtimaki, T., Rontu, R., & Keltikangas-Jarvinen, L. (2007). 
Tryptophan hydroxylase 1 gene (TPH1) moderates the influence of social support on 
depressive symptoms in adults. J Affect Disord, 100(1-3), 191-197. 
Kahn, R. S., Khoury, J., Nichols, W. C., & Lanphear, B. P. (2003). Role of dopamine transporter 
genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, 
and oppositional behaviors. J Pediatr, 143(1), 104-110. 
Kaufman, J., Yang, B. Z., Douglas-Palumberi, H., Crouse-Artus, M., Lipschitz, D., Krystal, J. 
H., et al. (2007). Genetic and environmental predictors of early alcohol use. Biol 
Psychiatry, 61(11), 1228-1234. 
Kaufman, J., Yang, B. Z., Douglas-Palumberi, H., Grasso, D., Lipschitz, D., Houshyar, S., et al. 
(2006). Brain-derived neurotrophic factor-5-HTTLPR gene interactions and 
environmental modifiers of depression in children. Biol Psychiatry, 59(8), 673-680. 
Kaufman, J., Yang, B. Z., Douglas-Palumberi, H., Houshyar, S., Lipschitz, D., Krystal, J. H., et 
al. (2004). Social supports and serotonin transporter gene moderate depression in 
maltreated children. Proc Natl Acad Sci U S A, 101(49), 17316-17321. 
Keltikangas-Jarvinen, L., Raikkonen, K., Ekelund, J., & Peltonen, L. (2004). Nature and nurture 
in novelty seeking. Mol Psychiatry, 9(3), 308-311. 
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999). Causal relationship between 
stressful life events and the onset of major depression. Am J Psychiatry, 156(6), 837-841. 
Kendler, K. S., Kessler, R. C., Walters, E. E., MacLean, C., Neale, M. C., Heath, A. C., et al. 
(1995). Stressful life events, genetic liability, and onset of an episode of major depression 
in women. Am J Psychiatry, 152(6), 833-842. 
Kendler, K. S., Kuhn, J. W., Vittum, J., Prescott, C. A., & Riley, B. (2005). The interaction of 
stressful life events and a serotonin transporter polymorphism in the prediction of 
episodes of major depression: a replication. Arch Gen Psychiatry, 62(5), 529-535. 
46 
 
Kilpatrick, D. G., Koenen, K. C., Ruggiero, K. J., Acierno, R., Galea, S., Resnick, H. S., et al. 
(2007). The serotonin transporter genotype and social support and moderation of 
posttraumatic stress disorder and depression in hurricane-exposed adults. Am J 
Psychiatry, 164(11), 1693-1699. 
Kim, J. M., Stewart, R., Kim, S. W., Yang, S. J., Shin, I. S., Kim, Y. H., et al. (2007). 
Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on 
depression in Korean elders. Biol Psychiatry, 62(5), 423-428. 
Kim-Cohen, J., Caspi, A., Taylor, A., Williams, B., Newcombe, R., Craig, I. W., et al. (2006). 
MAOA, maltreatment, and gene-environment interaction predicting children's mental 
health: new evidence and a meta-analysis. Mol Psychiatry, 11(10), 903-913. 
Kluger, A. N., Siegfried, Z., & Ebstein, R. P. (2002). A meta-analysis of the association between 
DRD4 polymorphism and novelty seeking. Molecular Psychiatry, 7(7), 712-717. 
Koenen, K. C., Aiello, A. E., Bakshis, E., Amstadter, A. B., Ruggiero, K. J., Acierno, R., et al. 
(2009). Modification of the Association Between Serotonin Transporter Genotype and 
Risk of Posttraumatic Stress Disorder in Adults by County-Level Social Environment. 
American Journal of Epidemiology, 169(6), 704-711. 
Lahti, J., Raikkonen, K., Ekelund, J., Peltonen, L., Raitakari, O. T., & Keltikangas-Jarvinen, L. 
(2006). Socio-demographic characteristics moderate the association between DRD4 and 
Novelty seekign. Personality and Individual Differences, 40, 533-543. 
Langley, K., Turic, D., Rice, F., Holmans, P., van den Bree, M. B. M., Craddock, N., et al. 
(2008). Testing for Gene x Environment Interaction Effects in Attention Deficit 
Hyperactivity Disorder and Associated Antisocial Behavior. American Journal of 
Medical Genetics Part B-Neuropsychiatric Genetics, 147B(1), 49-53. 
Lasky-Su, J., Faraone, S. V., Lange, C., Tsuang, M. T., Doyle, A. E., Smoller, J. W., et al. 
(2007). A study of how socioeconomic status moderates the relationship between SNPs 
encompassing BDNF and ADHD symptom counts in ADHD families. Behav Genet, 
37(3), 487-497. 
Lasky-Su, J. A., Faraone, S. V., Glatt, S. J., & Tsuang, M. T. (2005). Meta-analysis of the 
association between two polymorphisms in the serotonin transporter gene and affective 
disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 
133B(1), 110-115. 
47 
 
Laucht, M., Skowronek, M. H., Becker, K., Schmidt, M. H., Esser, G., Schulze, T. G., et al. 
(2007). Interacting effects of the dopamine transporter gene and psychosocial adversity 
on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-
risk community sample. Arch Gen Psychiatry, 64(5), 585-590. 
Laucht, M., Treutlein, J., Blomeyer, D., Buchmann, A. F., Schmid, B., Becker, K., et al. (2009). 
Interaction between the 5-HTTLPR serotonin transporter polymorphism and 
environmental adversity for mood and anxiety psychopathology: evidence from a high-
risk community sample of young adults. International Journal of 
Neuropsychopharmacology, 12(6), 737-747. 
Laucht, M., Treutlein, J., Schmid, B., Blomeyer, D., Becker, K., Buchmann, A. F., et al. (2009). 
Impact of psychosocial adversity on alcohol intake in young adults: moderation by the 
LL genotype of the serotonin transporter polymorphism. Biol Psychiatry, 66(2), 102-109. 
Lesch, K. P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., et al. (1996). 
Association of anxiety-related traits with a polymorphism in the serotonin transporter 
gene regulatory region. Science, 274(5292), 1527-1531. 
Lyons, L. A., Imes, D. L., Rah, H. C., & Grahn, R. A. (2005). Tyrosinase mutations associated 
with Siamese and Burmese patterns in the domestic cat (Felis catus). Animal Genetics, 
36(2), 119-126. 
Madrid, G. A., MacMurray, J., Lee, J. W., Anderson, B. A., & Comings, D. E. (2001). Stress as a 
mediating factor in the association between the DRD2 TaqI polymorphism and 
alcoholism. Alcohol, 23(2), 117-122. 
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. 
(2009). Finding the missing heritability of complex diseases. Nature, 461(7265), 747-
753. 
McClelland, G. H., & Judd, C. M. (1993). Statistical Difficulties of Detecting Interactions and 
Moderator Effects. Psychological Bulletin, 114(2), 376-390. 
Moffitt, T. E., Caspi, A., & Rutter, M. (2005). Strategy for investigating interactions between 
measured genes and measured environments. Arch Gen Psychiatry, 62(5), 473-481. 
Moffitt, T. E., Caspi, A., & Rutter, M. (2006). Measured gene-environment interactions in 
psychopathology. Perspectives on Psychological Science, 1(1), 5-27. 
48 
 
Munafo, M. R., Clark, T. G., Moore, L. R., Payne, E., Walton, R., & Flint, J. (2003). Genetic 
polymorphisms and personality in healthy adults: a systematic review and meta-analysis. 
Mol Psychiatry, 8(5), 471-484. 
Munafo, M. R., Durrant, C., Lewis, G., & Flint, J. (2009). Gene X environment interactions at 
the serotonin transporter locus. Biol Psychiatry, 65(3), 211-219. 
Neuman, R. J., Lobos, E., Reich, W., Henderson, C. A., Sun, L. W., & Todd, R. D. (2007). 
Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD 
subtype. Biological Psychiatry, 61(12), 1320-1328. 
Nilsson, K. W., Sjoberg, R. L., Damberg, M., Leppert, J., Ohrvik, J., Alm, P. O., et al. (2006). 
Role of monoamine oxidase A genotype and psychosocial factors in male adolescent 
criminal activity. Biol Psychiatry, 59(2), 121-127. 
Nobile, M., Giorda, R., Marino, C., Carlet, O., Pastore, V., Vanzin, L., et al. (2007). 
Socioeconomic status mediates the genetic contribution of the dopamine receptor D4 and 
serotonin transporter linked promoter region repeat polymorphisms to externalization in 
preadolescence. Development and Psychopathology, 19(4), 1147-1160. 
Nobile, M., Rusconi, M., Bellina, M., Marino, C., Giorda, R., Carlet, O., et al. (2009). The 
influence of family structure, the TPH2 G-703T and the 5-HTTLPR serotonergic genes 
upon affective problems in children aged 10-14 years. Journal of Child Psychology and 
Psychiatry, 50(3), 317-325. 
Ozkaragoz, T., & Noble, E. P. (2000). Extraversion. Interaction between D2 dopamine receptor 
polymorphisms and parental alcoholism. Alcohol, 22(3), 139-146. 
Perroud, N., Courtet, P., Vincze, I., Jaussent, I., Jollant, F., Bellivier, F., et al. (2008). Interaction 
between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes 
Brain and Behavior, 7(3), 314-322. 
Pietz, J., Kreis, R., Rupp, A., Mayatepek, E., Rating, D., Boesch, C., et al. (1999). Large neutral 
amino acids block phenylalanine transport into brain tissue in patients with 
phenylketonuria. Journal of Clinical Investigation, 103(8), 1169-1178. 
Plomin, R., & Davis, O. S. (2009). The future of genetics in psychology and psychiatry: 
microarrays, genome-wide association, and non-coding RNA. J Child Psychol 
Psychiatry, 50(1-2), 63-71. 
49 
 
Polanczyk, G., Caspi, A., Williams, B., Price, T. S., Danese, A., Sugden, K., et al. (2009). 
Protective effect of CRHR1 gene variants on the development of adult depression 
following childhood maltreatment: replication and extension. Arch Gen Psychiatry, 
66(9), 978-985. 
Power, T., Stewart, R., Ancelin, M. L., Jaussent, I., Malafosse, A., & Ritchie, K. (2010). 5-
HTTLPR genotype, stressful life events and late-life depression: No evidence of 
interaction in a French population. Neurobiology of Aging, 31(5), 886-887. 
Prom-Wormley, E. C., Eaves, L. J., Foley, D. L., Gardner, C. O., Archer, K. J., Wormley, B. K., 
et al. (2009). Monoamine oxidase A and childhood adversity as risk factors for conduct 
disorder in females. Psychological Medicine, 39(4), 579-590. 
Propper, C., Willoughby, M., Halpern, C. T., Carbone, M. A., & Cox, M. (2007). Parenting 
quality, DRD4, and the prediction of externalizing and internalizing Behaviors in early 
childhood. Developmental Psychobiology, 49(6), 619-632. 
Racine, S. E., Culbert, K. M., Larson, C. L., & Klump, K. L. (2009). The possible influence of 
impulsivity and dietary restraint on associations between serotonin genes and binge 
eating. Journal of Psychiatric Research, 43(16), 1278-1286. 
Reif, A., Rosler, M., Freitag, C. M., Schneider, M., Eujen, A., Kissling, C., et al. (2007). Nature 
and nurture predispose to violent behavior: Serotonergic genes and adverse childhood 
environment. Neuropsychopharmacology, 32(11), 2375-2383. 
Retz, W. G., Freitag, C. M., Retz-Junginger, P., Wenzler, D., Schneider, M., Kissling, C., et al. 
(2008). A functional serotonin transporter promoter gene polymorphism increases ADHD 
symptoms in delinquents: Interaction with adverse childhood environment. Psychiatry 
Research, 158(2), 123-131. 
Risch, N., Herrell, R., Lehner, T., Liang, K. Y., Eaves, L., Hoh, J., et al. (2009). Interaction 
between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of 
depression: a meta-analysis. Jama, 301(23), 2462-2471. 
Rogers, W. M. (2002). Theoretical and mathematical constraints of interactive regression 
models. Organizational Research Methods, 5(3), 212-230. 
Roy, A., Hu, X. Z., Janal, M. N., & Goldman, D. (2007). Interaction between childhood trauma 
and serotonin transporter gene variation in suicide. Neuropsychopharmacology, 32(9), 
2046-2052. 
50 
 
Rutter, M., Thapar, A., & Pickles, A. (2009). Gene-Environment Interactions Biologically Valid 
Pathway or Artifact? Archives of General Psychiatry, 66(12), 1287-1289. 
Scheid, J. M., Holzman, C. B., Jones, N., Friderici, K. H., Nummy, K. A., Symonds, L. L., et al. 
(2007). Depressive symptoms in mid-pregnancy, lifetime stressors and the 5-HTTLPR 
genotype. Genes Brain Behav, 6(5), 453-464. 
Schinka, J. A., Letsch, E. A., & Crawford, F. C. (2002). DRD4 and novelty seeking: Results of 
meta-analyses. American Journal of Medical Genetics, 114(6), 643-648. 
Seeger, G., Schloss, P., Schmidt, M. H., Ruter-Jungfleisch, A., & Henn, F. A. (2004). Gene-
environment interaction in hyperkinetic conduct disorder (HD+CD) as indicated by 
season of birth variations in dopamine receptor (DRD4) gene polymorphism. 
Neuroscience Letters, 366(3), 282-286. 
Sjoberg, R. L., Nilsson, K. W., Nordquist, N., Ohrvik, J., Leppert, J., Lindstrom, L., et al. (2006). 
Development of depression: sex and the interaction between environment and a promoter 
polymorphism of the serotonin transporter gene. Int J Neuropsychopharmacol, 9(4), 443-
449. 
Sjoberg, R. L., Nilsson, K. W., Wargelius, H. L., Leppert, J., Lindstrom, L., & Oreland, L. 
(2007). Adolescent girls and criminal activity: role of MAOA-LPR genotype and 
psychosocial factors. Am J Med Genet B Neuropsychiatr Genet, 144B(2), 159-164. 
Sonuga-Barke, E. J. S., Oades, R. D., Psychogiou, L., Chen, W., Franke, B., Buitelaar, J., et al. 
(2009). Dopamine and serotonin transporter genotypes moderate sensitivity to maternal 
expressed emotion: the case of conduct and emotional problems in attention 
deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry, 50(9), 1052-
1063. 
Stein, M. B., Schork, N. J., & Gelernter, J. (2008). Gene-by-environment (serotonin transporter 
and childhood maltreatment) interaction for anxiety sensitivity, an intermediate 
phenotype for anxiety disorders. Neuropsychopharmacology, 33(2), 312-319. 
Stevens, S. E., Kumsta, R., Kreppner, J. M., Brookes, K. J., Rutter, M., & Sonuga-Barke, E. J. S. 
(2009). Dopamine Transporter Gene Polymorphism Moderates the Effects of Severe 
Deprivation on ADHD Symptoms: Developmental Continuities in Gene-Environment 
Interplay. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 
150B(6), 753-761. 
51 
 
Sullivan, P. F. (2007). Spurious genetic associations. Biol Psychiatry, 61(10), 1121-1126. 
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003). Schizophrenia as a complex trait - 
Evidence from a meta-analysis of twin studies. Archives of General Psychiatry, 60(12), 
1187-1192. 
Sullivan, P. F., Neale, M. C., & Kendler, K. S. (2000). Genetic epidemiology of major 
depression: review and meta-analysis. Am J Psychiatry, 157(10), 1552-1562. 
Sun, N., Xu, Y., Wang, Y. F., Duan, H. J., Wang, S., Ren, Y., et al. (2008). The combined effect 
of norepinephrine transporter gene and negative life events in major depression of 
Chinese Han population. Journal of Neural Transmission, 115(12), 1681-1686. 
Surtees, P. G., Wainwright, N. W., Willis-Owen, S. A., Luben, R., Day, N. E., & Flint, J. (2006). 
Social adversity, the serotonin transporter (5-HTTLPR) polymorphism and major 
depressive disorder. Biol Psychiatry, 59(3), 224-229. 
Taylor, S. E., Way, B. M., Welch, W. T., Hilmert, C. J., Lehman, B. J., & Eisenberger, N. I. 
(2006). Early family environment, current adversity, the serotonin transporter promoter 
polymorphism, and depressive symptomatology. Biol Psychiatry, 60(7), 671-676. 
Todd, R. D., & Neuman, R. J. (2007). Rapid publication - Gene-environment interactions in the 
development of combined type ADHD: Evidence for a synapse-based model. American 
Journal of Medical Genetics Part B-Neuropsychiatric Genetics, 144B(8), 971-975. 
Valdar, W., Solberg, L. C., Gauguier, D., Cookson, W. O., Rawlins, J. N. P., Mott, R., et al. 
(2006). Genetic and environmental effects on complex traits in mice. Genetics, 174(2), 
959-984. 
van Winkel, R., Henquet, C., Rosa, A., Papiol, S., Fananas, L., De Hert, M., et al. (2008). 
Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in 
psychosis: an experience-sampling study. Am J Med Genet B Neuropsychiatr Genet, 
147B(1), 10-17. 
Vanyukov, M. M., Maher, B. S., Devlin, B., Kirillova, G. P., Kirisci, L., Yu, L. M., et al. (2007). 
The MAOA promoter polymorphism, disruptive behavior disorders, and early onset 
substance use disorder: gene-environment interaction. Psychiatric Genetics, 17(6), 323-
332. 
52 
 
Waldman, I. D. (2007). Gene-environment interactions reexamined: does mother's marital 
stability interact with the dopamine receptor D2 gene in the etiology of childhood 
attention-deficit/hyperactivity disorder? Dev Psychopathol, 19(4), 1117-1128. 
Wichers, M., Kenis, G., Jacobs, N., Mengelers, R., Derom, C., Vlietinck, R., et al. (2008). The 
BDNF Val(66)Met x 5-HTTLPR x child adversity interaction and depressive symptoms: 
An attempt at replication. Am J Med Genet B Neuropsychiatr Genet, 147B(1), 120-123. 
Widom, C. S., & Brzustowicz, L. M. (2006). MAOA and the "Cycle of violence": Childhood 
abuse and neglect, MAOA genotype, and risk for violent and antisocial behavior. 
Biological Psychiatry, 60(7), 684-689. 
Wilhelm, K., Mitchell, P. B., Niven, H., Finch, A., Wedgwood, L., Scimone, A., et al. (2006). 
Life events, first depression onset and the serotonin transporter gene. Br J Psychiatry, 
188, 210-215. 
Xu, Y., Li, F., Huang, X. Z., Sun, N., Zhang, F. Q., Liu, P. Z., et al. (2009). The norepinephrine 
transporter gene modulates the relationship between urban/rural residency and major 
depressive disorder in a Chinese population. Psychiatry Research, 168(3), 213-217. 
Yen, Y. C., Rebok, G. W., Yang, M. J., & Lung, F. W. (2008). A multilevel analysis of the 
influence of Apolipoprotein E genotypes on depressive symptoms in late-life moderated 
by the environment. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 
32(2), 479-486. 
Young, S. E., Smolen, A., Hewitt, J. K., Haberstick, B. C., Stallings, M. C., Corley, R. P., et al. 
(2006). Interaction between MAO-A genotype and maltreatment in the risk for conduct 
disorder: failure to confirm in adolescent patients. Am J Psychiatry, 163(6), 1019-1025. 
Zalsman, G., Huang, Y. Y., Oquendo, M. A., Burke, A. K., Hu, X. Z., Brent, D. A., et al. (2006). 
Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) 
polymorphism with stressful life events and severity of depression. Am J Psychiatry, 
163(9), 1588-1593. 
Zhang, K., Xu, Q., Xu, Y., Yang, H., Luo, J., Sun, Y., et al. (2009). The combined effects of the 
5-HTTLPR and 5-HTR1A genes modulates the relationship between negative life events 
and major depressive disorder in a Chinese population. J Affect Disord, 114(1-3), 224-
231. 
 
53 
 
FIRST 
AUTHOR 
TITLE YEA
R 
N 
sample 
Aguilera Early adversity and 5-HTT/BDNF genes: new evidence of 
gene–environment interactions on depressive symptoms in a 
general population 
2009 534 
Altink The dopamine receptor D4 7-repeat allele and prenatal 
smoking in ADHD-affected children and their unaffected 
siblings: no gene–environment interaction 
2008 946 
Amstadter Variant in RGS2 moderates posttraumatic stress symptoms 
following potentially traumatic event exposure 
2009 607 
Bakermans-
Kranenburg 
Gene-environment interaction of the dopamine D4 receptor 
(DRD4) and observed maternal insensitivity predicting 
externalizing behavior in preschoolers 
2006 47 
Bau The TaqI A1 allele of the dopamine D2 receptor gene and 
alcoholism in Brazil: Association and interaction with stress 
and harm avoidance on severity prediction 
2000 229 
Becker Interaction of dopamine transporter genotype with prenatal 
smoke exposure on ADHD symptoms 
2008 305 
Bet Glucocorticoid Receptor Gene Polymorphisms and 
Childhood Adversity Are Associated With Depression: New 
Evidence for a Gene–Environment Interaction 
2009 906 
Binder Association of FKBP5 polymorphisms and childhood abuse 
with risk of posttraumatic stress disorder symptoms in 
adults 
2008 676 
Blomeyer Interaction between CRHR1 gene and stressful life events 
predicts adolescent heavy alcohol use 
2008 280 
Bradley Influence of Child Abuse on Adult Depression  Moderation 
by the Corticotropin-Releasing Hormone Receptor Gene 
2009 422 & 
204 
Brookes Differential dopamine receptor D4 allele association with 
ADHD dependent of (sic) proband season of birth 
2008 1110 
Brummett Effects of environmental stress and gender on associations 
among symptoms of depression and the serotonin 
transporter gene linked polymorphic region (5-HTTLPR) 
2008 288 & 
142 
Caspi-1 Role of genotype in the cycle of violence in maltreated 
children 
2002 442 
Caspi-2 Moderation of the effect of adolescent-onset cannabis use 
on adult psychosis by a functional polymorphism in the 
catechol-O-methyltransferase gene: longitudinal evidence of 
a gene X environment interaction 
2005 803 
Caspi-3 Influence of life stress on depression: moderation by a 
polymorphism in the 5-HTT gene 
2003 847 
Cervilla The risk for depression conferred by stressful life events is 
modified by variation at the serotonin transporter 5HTTLPR 
genotype: evidence from the Spanish PREDICT-Gene 
cohort 
2007 737 
54 
 
Chipman No interaction between the serotonin transporter 
polymorphism (5-HTTLPR) and childhood adversity or 
recent stressful life events on symptoms of depression: 
Results from two community surveys 
2007 2095 & 
584 
Chorbov Relationship of 5-HTTLPR genotypes and depression risk 
in the presence of trauma in a female twin sample 
2007 247 
Chotai Gene-environment interaction in psychiatric disorders as 
indicated by season of birth variations in tryptophan 
hydroxylase (TPH), serotonin transporter (5-HTTLPR) and 
dopamine receptor (DRD4) gene polymorphisms 
2003 1349 
Cicchetti Interactions of child maltreatment and serotonin transporter 
and monoamine oxidase A polymorphisms: Depressive 
symptomatology among adolescents from low 
socioeconomic status backgrounds 
2007 339 
Covault Interactive effects of the serotonin transporter 5-HTTLPR 
polymorphism and stressful life events on college student 
drinking and drug use 
2007 302 
Dick Marital status, alcohol dependence, and GABRA2: 
Evidence for gene-environment correlation and interaction 
2006 1916 & 
915 
DiLalla Genetic and Gene–Environment Interaction Effects on 
Preschoolers’ Social Behaviors 
2009 62 
Ducci Interaction between a functional MAOA locus and 
childhood sexual abuse predicts alcoholism and antisocial 
personality disorder in adult women 
2008 187 
Eley Gene-environment interaction analysis of serotonin system 
markers with adolescent depression   
2006 377 
Foley Childhood adversity, monoamine oxidase A genotype, and 
risk for conduct disorder 
2004 514 
Fox Evidence for a gene-environment interaction in predicting 
behavioral inhibition in middle childhood 
2008 73 
Frazzetto Early trauma and increased risk for physical aggression 
during adulthood: The moderating role of MAOA genotype 
2007 235 
Gacek Tryptophan hydroxylase 2 gene and alcohol use among 
college students 
2008 351 
Gervai Infant genotype may moderate sensitivity to maternal 
affective communications: attachment disorganization, 
quality of care, and the DRD4 polymorphism 
2007 96 
Gibb Serotonin tansporter (5-HTTLPR) genotype, childhood 
abuse, and suicide attempts in adult psychiatric inpatients 
2006 30 
Gillespie The relationship between stressful life events, the serotonin 
transporter (5-HTTLPR) genotype and major depression 
2004 1091 
Grabe-1 Mental and physical distress is modulated by a 
polymorphism in the 5-HT transporter gene interacting with 
social stressors and chronic disease burden 
2005 976 
Grabe-2 Serotonin transporter gene (SLC6A4) promoter 2009 3045 
55 
 
polymorphisms and the susceptibility to posttraumatic stress 
disorder in the general population 
Gunthert Serotonin transporter gene polymorphism (5-HTTLPR) and 
anxiety reactivity in daily life: a daily process appreoach to 
gene-environment interaction 
2007 350 
Haberstick Monoamine oxidase A (MAOA) genotype and antisocial 
behaviors in the presence of childhood and adolescent 
maltreatment 
2005 774 
Haeffel Association between polymorphisms in the dopamine 
transporter gene and depression 
2008 176 
Henquet COMT Val158Met moderation of cannabis-induced 
psychosis: a momentary assessment study of 'switching on' 
hallucinations in the flow of daily life 
2009 61 
Huizinga Childhood maltreatment, subsequent antisocial behavior, 
and the role of monoamine oxidase A genotype 
2006 277 
Jacobs Stress-related negative affectivity and genetically altered 
serotonin transporter function: evidence of synergism in 
shaping risk of depression 
2006 374 
Jokela-1 Serotonin receptor 2A gene and the influence of childhood 
maternal nurturance on adulthood depressive symptoms 
2007 1212 
Jokela-2 The influence of urban/rural residency on depressive 
symptoms is moderated by the serotonin receptor 2A gene 
2007 1224 
Jokela-3 The serotonin receptor 2A gene moderates the influence of 
parental socioeconomic status on adulthood harm avoidance 
2007 1246 
Jokela-4 Tryptophan hydroxylase 1 gene (TPH1) moderates the 
influence of social support on depressive symptoms in 
adults 
2007 341 
Kahn Role of dopamine transporter genotype and maternal 
prenatal smoking in childhood hyperactive-impulsive, 
inattentive, and oppositional behaviors 
2003 161 
Kaufman-1 Social supports and serotonin transporter gene moderate 
depression in maltreated children 
2004 101 
Kaufman-2 Brain-derived neurotrophic factor-5-HTTLPR gene 
interactions and environmental modifiers of depression in 
children. 
2007 196 
Kaufman-3 Genetic and environmental predictors of early alcohol use 2007 127 
Keltikangas
-Jarvinen 
Nature and nurture in novelty seeking 2004 92 
Kendler The interaction of stressful life events and a serotonin 
transporter polymorphism in the prediction of episodes of 
major depression.  A replication 
2005 549 
Kilpatrick The serotonin transporter genotype and social support and 
moderation of posttraumatic stress disorder and depression 
in hurricane-exposed adults 
2007 589 
Kim Interactions between life stressors and susceptibility genes 2007 732 
56 
 
(5-HTTLPR and BDNF) on depression in korean elders 
Kim-Cohen MAOA, maltreatment, and gene-environment interaction 
predicting children's mental health: new evidence and a 
meta-analysis. 
2006 975 
Koenen Modification of the association between serotonin 
transporter genotype and risk of posttraumatic stress 
disorder in adults by county-level social environment 
2009 651 
Lahti Socio-demographic characteristics moderate the association 
between DRD4 and Novelty seeking 
2006 154 
Langley Testing for gene x environment interaction effects in 
attention deficit hyperactivity disorder and associated 
antisocial behavior 
2008 266 
Lasky-Su A study of how socioeconomic status moderates the 
relationship between SNPs encompassing BDNF and 
ADHD symptom counts in ADHD Families 
2007 345 
Laucht-1 Interacting effects of the dopamine transporter gene and 
psychosocial adversity on attention-deficit/hyperactivity 
disorder symptoms among 15-year-olds from a high-risk 
community sample 
2007 305 
Laucht-2 Interaction between the 5-HTTLPR serotonin transporter 
polymorphism and environmental adversity for mood and 
anxiety psychopathology: evidence from a high-risk 
community sample of young adults 
2009 309 
Laucht-3 Impact of psychosocial adversity on alcohol intake in young 
adults: Moderation by the LL genotype of the serotonin 
transporter polymorphism 
2009 309 
Madrid Stress as a mediating factor in the association between the 
DRD2 TaqI polymorphism and alcoholism 
2001 304 
Neuman Prenatal smoking exposure and dopaminergic genotypes 
interact to cause a severe ADHD subtype 
2007 770 
Nilsson Role of monoamine oxidase A genotype and psychosocial 
factors in male adolescent criminal activity 
2007 81 
Nobile-1 Socioeconomic status mediates the genetic contribution of 
the dopamine receptor D4 and serotonin transporter linked 
promoter region repeat polymorphisms to externalization in 
preadolescence 
2007 607 
Nobile-1 The influence of family structure the TPH2 G703T and the 
5HTTLPR serotonergic genes upon affective problems in 
children aged 10 14 years 
2009 607 
Ozkaragoz Extraversion. Interaction between D2 dopamine receptor 
polymorphisms and parental alcoholism. 
2000 98 
Perroud Interaction between BDNF Val66Met and childhood trauma 
on adult’s violent suicide attempt 
2008 813 
Polanczyk Protective Effect of CRHR1 Gene Variants on the 
Development of Adult Depression Following Childhood 
2009 1037 &  
1116 
57 
 
Maltreatment 
Power 5-HTTLPR genotype, stressful life events and late-life 
depression: No evidence of interaction in a French 
population 
2008 1421 
Prom-
Wormley 
Monoamine oxidase A and childhood adversity as risk 
factors for conduct disorder in females 
2009 721 
Propper Parenting quality, DRD4, and the prediction of 
externalizing and internalizing behaviors in early childhood 
2007 169 
Racine The possible influence of impulsivity and dietary restraint 
on associations between serotonin genes and binge eating 
2009 344 
Reif Nature and nurture predispose to violent behavior: 
serotonergic genes and adverse childhood environment 
2007 184 
Retz A functional serotonin transporter promoter gene 
polymorphism increases ADHD symptoms in delinquents: 
Interaction with adverse childhood environment 
2008 184 
Roy Interaction between childhood trauma and serotonin 
transporter gene variation in suicide 
2007 306 
Scheid Depressive symptoms in mid-pregnancy, lifetime stressors 
and the 5-HTTLPR genotype 
2007 568 
Seeger Gene–environment interaction in hyperkinetic conduct 
disorder (HD + CD) as indicated by season of birth 
variations in dopamine receptor (DRD4) gene 
polymorphism 
2004 227 
Sjoberg-1 Development of depression: sex and the interaction between 
environment and a promoter polymorphism of the serotonin 
transporter gene 
2006 180 
Sjoberg-2 Adolescent girls and criminal activity: Role of MAOA-LPR 
genotype and psychosocial factors 
2007 119 
Sonuga-
Barke 
Dopamine and serotonin transporter genotypes moderate 
sensitivity to maternal expressed emotion: the case of 
conduct and emotional problems in attention 
deficit/hyperactivity disorder 
2009 728 
Stein Gene-by-environment (serotonin transporter and childhood 
maltreatment) interaction for anxiety sensitivity, an 
intermediate phenotype for anxiety disorders 
2008 150 
Stevens Dopamine transporter gene polymorphism moderates the 
effects of severe deprivation on ADHD symptoms: 
developmental continuities in gene–environment interplay 
2009 217 
Sun The combined effect of norepinephrine transporter gene and 
negative life events in major depression of Chinese Han 
population 
2008 776 
Surtees Social adversity, the serotonin transporter (5-HTTLPR) 
polymorphism and major depressive disorder 
2005 4175 
Taylor Early family environment, current adversity, the serotonin 
transporter promoter polymorphism, and depressive 
2006 118 
58 
 
symptomatology 
Todd Gene–environment interactions in the development of 
combined type ADHD:  Evidence for a synapse-based 
model 
2007 770 
van Winkel Evidence that the COMTVal158Met polymorphism 
moderates sensitivity to stress in psychosis 
2008 56 
Vanyukov The MAOA promoter polymorphism, disruptive behavior 
disorders, and early onset substance use disorder: gene–
environment interaction 
2007 148 
Waldman Gene-environment interactions reexamined: Does mother's 
marital stability interact with the dopamine receptor D2 
gene in the etiology of childhood attention-
deficit/hyperactivity disorder? 
2007 211 
Wichers The BDNF Val66Met ! 5-HTTLPR ! child adversity 
interaction and depressive symptoms: An attempt at 
replication 
2008 621 
Widom MAOA and the “Cycle of Violence:” Childhood abuse and 
neglect, MAOA genotype, and risk for violent and 
antisocial behavior 
2006 409 
Wilhelm Life events, first depression onset and the serotonin 
transporter gene 
2006 127 
Xu The norepinephrine transporter gene modulates the 
relationship between urban/rural residency and major 
depressive disorder in a Chinese population 
2009 835 
Yen A multilevel analysis of the influence of Apolipoprotein E 
genotypes on depressive symptoms in late-life moderated 
by the environment 
2008 301 
Young Interaction between MAO-A genotype and maltreatment in 
the risk for conduct disorder: Failure to confirm in 
adolescent patients. 
2006 247 
Zalsman Association of a triallelic serotonin transporter gene 
promoter region (5-HTTLPR) polymorphism with stressful 
life events and severity of depression 
2006 316 
Zhang The combined effects of the 5-HTTLPR and 5-HTR1A 
genes modulates the relationship between negative life 
events and major depressive disorder in a Chinese 
population 
2009 792 
 
